Ping Peng: Clinical Trials

1 trial sponsored by Ping Peng, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Ping Peng: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Orlistat Overcoming Third-generation EGFR-TKI Resistance
Orlistat 120 mg - Lung Adenocarcinoma, Osimertinib
Phase 2Not yet recruitingPing Peng362025-02-162025-02-12

Conditions studied

Adenocarcinoma of Lung (1)

Interventions

Orlistat (1)